申请人:Eissenstat Michael
公开号:US20100056596A1
公开(公告)日:2010-03-04
Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.
提供了耐抗性和多药耐药的逆转录病毒蛋白酶抑制剂。还提供了包含这些化合物的制药组合物,以及使用这些化合物治疗哺乳动物HIV感染的方法。